Literature DB >> 25326748

Impact of the complexity of bifurcation lesions treated with drug-eluting stents: the DEFINITION study (Definitions and impact of complEx biFurcation lesIons on clinical outcomes after percutaNeous coronary IntervenTIOn using drug-eluting steNts).

Shao-Liang Chen1, Imad Sheiban2, Bo Xu3, Nigel Jepson4, Chitprapai Paiboon5, Jun-Jie Zhang6, Fei Ye6, Teugh Sansoto7, Tak W Kwan8, Michael Lee9, Ya-Ling Han10, Shu-Zheng Lv11, Shang-Yu Wen12, Qi Zhang13, Hai-Chang Wang14, Tie-Ming Jiang15, Yan Wang16, Liang-Long Chen17, Nai-Liang Tian18, Feng Cao14, Chun-Guang Qiu19, Yao-Jun Zhang6, Martin B Leon20.   

Abstract

OBJECTIVES: The present study established criteria to differentiate simple from complex bifurcation lesions and compared 1-year outcomes stratified by lesion complexity after provisional stenting (PS) and 2-stent techniques using drug-eluting stents.
BACKGROUND: Currently, no criterion can distinguish between simple and complex coronary bifurcation lesions. Comparisons of PS and 2-stent strategies stratified by lesion complexity have also not been reported previously.
METHODS: Criteria of bifurcation complexity in 1,500 patients were externally tested in another 3,660 true bifurcation lesions after placement of drug-eluting stents. The primary endpoint was the occurrence of a major adverse cardiac event (MACE) at 12 months. The secondary endpoint was the rate of stent thrombosis (ST).
RESULTS: Complex (n = 1,108) bifurcation lesions were associated with a higher 1-year rate of MACE (16.8%) compared with simple (n = 2,552) bifurcation lesions (8.9%) (p < 0.001). The in-hospital ST and 1-year target lesion revascularization rates after 2-stent techniques in the simple group (1.0% and 5.6%, respectively) were significantly different from those after PS (0.2% [p = 0.007] and 3.2% [p = 0.009], respectively); however, 1-year MACE rates were not significantly different between the 2 groups. For complex bifurcation lesions, 2-stent techniques had lower rates of 1-year cardiac death (2.8%) and in-hospital MACE (5.0%) compared with PS (5.3%, p = 0.047; 8.4%, p = 0.031).
CONCLUSIONS: Complex bifurcation lesions had higher rates of 1-year MACE and ST. The 2-stent and PS techniques were overall equivalent in 1-year MACE. However, 2-stent techniques for complex lesions elicited a lower rate of cardiac death and in-hospital MACE but higher rates of in-hospital ST and revascularization at 1 year for simple lesions.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary bifurcation lesion; drug-eluting stent; lesion complexity; major adverse cardiac event; stent thrombosis

Mesh:

Year:  2014        PMID: 25326748     DOI: 10.1016/j.jcin.2014.04.026

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  29 in total

Review 1.  Update on Provisional Technique for Bifurcation Interventions.

Authors:  Lazzaro Paraggio; Francesco Burzotta; Cristina Aurigemma; Carlo Trani
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

Review 2.  Treatment of Bifurcation Lesions: Has DK Crush"ed" the Competition?

Authors:  Bryce S Lynn; James B Hermiller
Journal:  Curr Cardiol Rep       Date:  2018-09-01       Impact factor: 2.931

3.  The Need For Dedicated Bifurcation Stents: A Critical Analysis.

Authors:  Maciej Lesiak
Journal:  Interv Cardiol       Date:  2016-10

4.  Intravascular ultrasound-guided drug-eluting stent implantation is associated with improved clinical outcomes in patients with unstable angina and complex coronary artery true bifurcation lesions.

Authors:  Liang Chen; Tian Xu; Xian-Jun Xue; Jun-Jie Zhang; Fei Ye; Nai-Liang Tian; Shao-Liang Chen
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-06       Impact factor: 2.357

5.  Stenting left main disease: all roads lead to Rome: Stenting left main disease.

Authors:  Shao-Liang Chen
Journal:  AsiaIntervention       Date:  2021-12

6.  Outcome of a polymer-free drug-coated coronary stent in bifurcation lesions-Pilot registry with serial OCT imaging.

Authors:  Hendrik Wienemann; Felix Meincke; Marius Vach; Christian-Hendrik Heeger; Annika Meyer; Tobias Spangenberg; Karl Heinz Kuck; Alexander Ghanem
Journal:  Herz       Date:  2022-04-09       Impact factor: 1.443

Review 7.  Systematic Review and Network Meta-Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention.

Authors:  Dae Yong Park; Seokyung An; Neeraj Jolly; Steve Attanasio; Neha Yadav; Sunil Rao; Aviral Vij
Journal:  J Am Heart Assoc       Date:  2022-06-20       Impact factor: 6.106

Review 8.  [Bifurcation lesions : Are new strategies and devices needed?]

Authors:  Luise Gaede
Journal:  Herz       Date:  2022-10-21       Impact factor: 1.740

9.  Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club.

Authors:  Francesco Burzotta; Jens Flensted Lassen; Thierry Lefèvre; Adrian P Banning; Yiannis S Chatzizisis; Thomas William Johnson; Miroslaw Ferenc; Sudhir Rathore; Remo Albiero; Manuel Pan; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Marco Zimarino; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2021-03-19       Impact factor: 6.534

10.  A new sequential two-stent strategy for treating true distal left main trifurcation lesion.

Authors:  Yu-Xiang Dai; Chen-Guang Li; Jia Huang; Ren-De Xu; Shu-Fu Chang; Hao Lu; Dao-Yuan Ren; Lei Ge; Ju-Ying Qian; Feng Zhang; Jun-Bo Ge
Journal:  J Geriatr Cardiol       Date:  2021-06-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.